Pipeline
February 25, 2015 – Staff Reports
Research Updates from ASH & SABCS
February 20, 2015 – Staff Reports
Council Would Accelerate Development of Prostate Cancer Diagnostics
February 20, 2015 – Beth Fand Incollingo
CancerFilms.org
February 20, 2015 – Elizabeth Whittington
Study Highlights Geographical Differences in Cervical Cancer Incidence
February 20, 2015 – Beth Fand Incollingo
When Your Life Is Touched by Cancer
February 20, 2015 – Beth Fand Incollingo
Help With the Costs of Targeted Drugs
February 20, 2015 – Len Lichtenfeld, MD
Symptom Management in Childhood Cancer Patients: There's an App for That
February 20, 2015 – Elizabeth Whittington
Higher Vitamin D Levels Associated With Better Outcomes in Colorectal Cancer
February 20, 2015 – Lauren M. Green
Brain Tumor Doesn't Stop Student Athlete from Raising $1 Million for Research
February 20, 2015 – Elizabeth Whittington
Camp Kesem for Kids
February 20, 2015 – Beth Fand Incollingo
Not Immune to Confusion: Immunotherapy to Treat Cancer
February 19, 2015 – Omid Hamid, MD
Gut Reaction
February 19, 2015 – Cheryl Alkon
Balancing Act
February 18, 2015 – Christina Izzo
Lining Up for Online Support
February 18, 2015 – Elizabeth Whittington
Grappling with Guilt
February 17, 2015 – Don Vaughan
Getting with the Program: Expanded Access Programs
February 17, 2015 – Tony Hagen
Outsmarting Melanoma
February 17, 2015 – Erik Ness
A Two-Way Street: Joan Lunden Shares Her Cancer Experience
February 16, 2015 – Beth Fand Incollingo
Put on a Happy Face
February 16, 2015 – Jeannette Moninger
Getting a Second Opinion
February 16, 2015 – Maryann Hammers
Amid FDA Regulation Plans, E-Cigarettes are Subject of Debate
February 16, 2015 – Beth Fand Incollingo
'Cross-Pollination" of Breast Cancer Knowledge was Encouraged at SABCS
February 16, 2015 – Debu Tripathy, MD
Comments From Our Readers
February 16, 2015
Pipeline
February 25, 2015 – Staff Reports
Research Updates from ASH & SABCS
February 20, 2015 – Staff Reports
Council Would Accelerate Development of Prostate Cancer Diagnostics
February 20, 2015 – Beth Fand Incollingo
CancerFilms.org
February 20, 2015 – Elizabeth Whittington
Study Highlights Geographical Differences in Cervical Cancer Incidence
February 20, 2015 – Beth Fand Incollingo
When Your Life Is Touched by Cancer
February 20, 2015 – Beth Fand Incollingo
Help With the Costs of Targeted Drugs
February 20, 2015 – Len Lichtenfeld, MD
Symptom Management in Childhood Cancer Patients: There's an App for That
February 20, 2015 – Elizabeth Whittington
Higher Vitamin D Levels Associated With Better Outcomes in Colorectal Cancer
February 20, 2015 – Lauren M. Green
Brain Tumor Doesn't Stop Student Athlete from Raising $1 Million for Research
February 20, 2015 – Elizabeth Whittington
Camp Kesem for Kids
February 20, 2015 – Beth Fand Incollingo
Not Immune to Confusion: Immunotherapy to Treat Cancer
February 19, 2015 – Omid Hamid, MD
Gut Reaction
February 19, 2015 – Cheryl Alkon
Balancing Act
February 18, 2015 – Christina Izzo
Lining Up for Online Support
February 18, 2015 – Elizabeth Whittington
Grappling with Guilt
February 17, 2015 – Don Vaughan
Getting with the Program: Expanded Access Programs
February 17, 2015 – Tony Hagen
Outsmarting Melanoma
February 17, 2015 – Erik Ness
A Two-Way Street: Joan Lunden Shares Her Cancer Experience
February 16, 2015 – Beth Fand Incollingo
Put on a Happy Face
February 16, 2015 – Jeannette Moninger
Getting a Second Opinion
February 16, 2015 – Maryann Hammers
Amid FDA Regulation Plans, E-Cigarettes are Subject of Debate
February 16, 2015 – Beth Fand Incollingo
'Cross-Pollination" of Breast Cancer Knowledge was Encouraged at SABCS
February 16, 2015 – Debu Tripathy, MD
Currently Viewing
Comments From Our Readers
February 16, 2015

Comments From Our Readers

Readers respond to past articles of CURE.
PUBLISHED February 16, 2015
CLARITY ABOUT INDOLENT LYMPHOMAS
Editor-In-Chief Debu Tripathy’s winter 2014 editorial titled “Most non-Hodgkin lymphomas can be cured, but new drugs are needed” is misleading. As a patient who was diagnosed with an indolent, and currently non-curable, form of lymphoma, it is my understanding that 50 to 60 percent of all lymphomas that are diagnosed are of the indolent type. While treatable, indolent lymphomas are not curable and often require a lifetime of treatment when relapses occur. I feel Dr. Tripathy’s failure to even mention this fact leaves people with the wrong impression.
Debra Konrad
Arlington Heights, Ill.

Dr. Tripathy responds: We would like to clarify that, while many cases of lymphoma are curable, low-grade lymphomas, particularly those that are stage 3 or 4, can be treatable, but are typically not curable. We clearly need newer and more effective therapies for these types of cases, as well.
. . . . .
HIGHLIGHTING BURKITT LYMPHOMA
Your magazine is always enlightening, and the article titled “A Long and Winding Road” was, as well. I was disappointed, though, to see no mention of Burkitt lymphoma. My husband was diagnosed with Burkitt in 2009—stage 4—and was entered into a clinical trial at Northwestern Memorial Hospital in Chicago. The study he participated in evaluated standard Magrath chemotherapy with the anticancer drug Rituxan (rituximab) and the anti-cancer drug Doxil, a newer liposomal version of doxorubicin. My husband recently celebrated his fifth year in remission, and his oncologist has even used the word “cured.” We have been very lucky. I realize this is a rare form of cancer, with only 1,200 people in the U.S. being diagnosed per year, but I hope you will consider including some small coverage on this disease in the future. Thank you.
Deb Korb
Chicago, Ill.
. . . . .
REIMBURSEMENT FOR LYMPHEDEMA GARMENTS
Thank you so much for your excellent article about lymphedema in the fall 2014 issue (Living with Lymphedema). In your article, you mention that some insurers won’t pay for the treatments. You need to know that Medicare does not pay for compression garments unless they are custom garments. My supplementary insurance will not pay because Medicare does not pay. 
Judy Gehman
San Jose, Calif.
. . . . .
PUTTING A SMALL STUDY INTO CONTEXT
Why publish, without comment, a letter [from Trish Miller, winter 2014 issue] citing some of the results of a very small study of breast cancer patients receiving radiation in the 1960s that concluded 92 percent had arm paralysis after 34 years [Johansson. Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys. 2000;48(3):745-750]? The study involved only 71 women, and radiation has changed drastically since the 1960s. Doses are much lower today and, in many cases, women receive treatment while lying prone, thus sparing vital organs and nerves. (Here’s a link citing more info about the study: http://www.nursingcenter.com/lnc/journalarticle?Article_ID=630714.) Yes, even today, radiation can cause damage, but the wording of this letter leads breast cancer patients who have had radiation to conclude that there is a very good chance, a 92 percent chance in “fact,” that they will eventually be paralyzed. Is this the kind of message you want to convey to your readers?
Ellen Terry Kessler
New York City
 
Managing Editor Beth Fand Incollingo responds: Our intention was to allow the letter’s writer to express a suggestion: that patients treated with radiation should be followed longer-term in order to track any late effects of therapy. We agree that we could have provided perspective about the Johansson study by explaining that it is older and may not represent outcomes consistent with today’s radiation regimens. Thank you for sharing that information.
. . . . .
MOVED BY COLUMN ABOUT BRODIE
I so enjoyed Carolyn Choate’s contribution to your fall 2014 Voices column with her article “Meeting Dr. Brodie.” As a fellow breast cancer survivor, I wept, then reread it with tears in my eyes – and, believe me, I don’t cry easily. How perfectly gracious of her to hunt out and connect with Dr. Brodie. Please extend my thanks to her for contributing.
Linda Wolpert
Boulder, Colo.
. . . . .
We want to know what you think about CURE magazine. Address your comments to editor@curetoday. If you prefer that your comment not be published, please indicate.
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In